Lincoln National Corp Senseonics Holdings, Inc. Transaction History

Lincoln National Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.96 - $1.34 $1,920 - $2,680	-2,000 Reduced 10.5%	17,050 $17,000
Q3 2022 Nov 03, 2022	BUY	$1.02 - $2.23 $2,040 - $4,460	2,000 Added 11.73%	19,050 $25,000
Q1 2022 May 09, 2022	SELL	$1.54 - $3.71 $7,700 - $18,550	-5,000 Reduced 22.68%	17,050 $34,000
Q4 2021 Jan 26, 2022	SELL	$2.58 - $3.91 $7,998 - $12,121	-3,100 Reduced 12.33%	22,050 $59,000
Q3 2021 Nov 05, 2021	BUY	$2.77 - $4.05 $13,850 - $20,250	5,000 Added 24.81%	25,150 $85,000
Q2 2021 Aug 13, 2021	BUY	$1.71 - $4.14 $6,284 - $15,214	3,675 Added 22.31%	20,150 $77,000
Q1 2021 May 10, 2021	SELL	$0.85 - $5.27 $2,346 - $14,545	-2,760 Reduced 14.35%	16,475 $43,000
Q3 2020 Nov 09, 2020	BUY	$0.36 - $0.53 $444 - $654	1,235 Added 6.86%	19,235 $7,000
Q1 2020 Apr 24, 2020	BUY	$0.56 - $1.62 $10,080 - $29,160	18,000 New	18,000 $11,000

136

61.6M

390K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $610M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.